GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Frontage Holdings Corp (HKSE:01521) » Definitions » Operating Margin %

Frontage Holdings (HKSE:01521) Operating Margin % : 8.48% (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Frontage Holdings Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Frontage Holdings's Operating Income for the six months ended in Dec. 2023 was HK$87 Mil. Frontage Holdings's Revenue for the six months ended in Dec. 2023 was HK$1,027 Mil. Therefore, Frontage Holdings's Operating Margin % for the quarter that ended in Dec. 2023 was 8.48%.

Warning Sign:

Frontage Holdings Corp operating margin has been in a 5-year decline. The average rate of decline per year is -9.3%.

The historical rank and industry rank for Frontage Holdings's Operating Margin % or its related term are showing as below:

HKSE:01521' s Operating Margin % Range Over the Past 10 Years
Min: 7.87   Med: 14.91   Max: 28.38
Current: 7.87


HKSE:01521's Operating Margin % is ranked better than
81.84% of 1030 companies
in the Biotechnology industry
Industry Median: -168.78 vs HKSE:01521: 7.87

Frontage Holdings's 5-Year Average Operating Margin % Growth Rate was -9.30% per year.

Frontage Holdings's Operating Income for the six months ended in Dec. 2023 was HK$87 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2023 was HK$160 Mil.


Frontage Holdings Operating Margin % Historical Data

The historical data trend for Frontage Holdings's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Frontage Holdings Operating Margin % Chart

Frontage Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Operating Margin %
Get a 7-Day Free Trial 14.36 14.20 15.46 14.08 7.87

Frontage Holdings Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.35 15.07 13.19 7.24 8.48

Competitive Comparison of Frontage Holdings's Operating Margin %

For the Biotechnology subindustry, Frontage Holdings's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Frontage Holdings's Operating Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Frontage Holdings's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Frontage Holdings's Operating Margin % falls into.



Frontage Holdings Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Frontage Holdings's Operating Margin % for the fiscal year that ended in Dec. 2023 is calculated as

Operating Margin %=Operating Income (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=159.687 / 2029.416
=7.87 %

Frontage Holdings's Operating Margin % for the quarter that ended in Dec. 2023 is calculated as

Operating Margin %=Operating Income (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=87.134 / 1026.981
=8.48 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Frontage Holdings  (HKSE:01521) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Frontage Holdings Operating Margin % Related Terms

Thank you for viewing the detailed overview of Frontage Holdings's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Frontage Holdings (HKSE:01521) Business Description

Traded in Other Exchanges
Address
700 Pennsylvania Drive, Exton, PA, USA, 19341
Frontage Holdings Corp is a contract research organization providing integrated, scientifically driven research, analytical and development services. Geographically the group operates in both PRC and North America. The services provided in the North American segment, include Bioanalytical, CMC, DMPK and Safety and Toxicology services in the USA and Canada. The service offered in PRC includes Bioanalytical, Bioequivalence and CMC services in the PRC. Further, it also provides bioanalytical services, which are offered throughout the drug discovery and development process both in the United States and China.

Frontage Holdings (HKSE:01521) Headlines

No Headlines